Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (26)
- Computing and Computational Sciences Directorate (38)
- Energy Science and Technology Directorate (223)
- Fusion and Fission Energy and Science Directorate
(24)
- Information Technology Services Directorate (3)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (135)
- User Facilities (27)
- (-) Isotope Science and Enrichment Directorate (7)
Researcher
- Mike Zach
- Alexander I Kolesnikov
- Alexei P Sokolov
- Andrew F May
- Annetta Burger
- Ben Garrison
- Brad Johnson
- Bruce Moyer
- Carter Christopher
- Chance C Brown
- Charlie Cook
- Christopher Hershey
- Craig Blue
- Daniel Rasmussen
- Debjani Pal
- Debraj De
- Gautam Malviya Thakur
- Hsin Wang
- Isaac Sikkema
- James Gaboardi
- James Klett
- Jeffrey Einkauf
- Jennifer M Pyles
- Jesse McGaha
- John Lindahl
- Joseph Olatt
- Justin Griswold
- Kevin Sparks
- Kunal Mondal
- Kuntal De
- Laetitia H Delmau
- Liz McBride
- Luke Sadergaski
- Mahim Mathur
- Matthew B Stone
- Mingyan Li
- Nedim Cinbiz
- Oscar Martinez
- Padhraic L Mulligan
- Sam Hollifield
- Sandra Davern
- Shannon M Mahurin
- Tao Hong
- Todd Thomas
- Tomonori Saito
- Tony Beard
- Victor Fanelli
- Xiuling Nie

Often there are major challenges in developing diverse and complex human mobility metrics systematically and quickly.

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

The technologies provide a system and method of needling of veiled AS4 fabric tape.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

ORNL will develop an advanced high-performing RTG using a novel radioisotope heat source.

Real-time tracking and monitoring of radioactive/nuclear materials during transportation is a critical need to ensure safety and security. Current technologies rely on simple tagging, using sensors attached to transport containers, but they have limitations.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence
